7-5900535-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015622.6(CCZ1):āc.281A>Gā(p.Asn94Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000668 in 149,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000067 ( 0 hom., cov: 26)
Exomes š: 0.00011 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
CCZ1
NM_015622.6 missense
NM_015622.6 missense
Scores
1
15
Clinical Significance
Conservation
PhyloP100: 4.31
Genes affected
CCZ1 (HGNC:21691): (CCZ1 homolog, vacuolar protein trafficking and biogenesis associated) Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in vesicle-mediated transport. Located in intracellular membrane-bounded organelle. Part of Mon1-Ccz1 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14238808).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCZ1 | NM_015622.6 | c.281A>G | p.Asn94Ser | missense_variant | 3/15 | ENST00000325974.9 | NP_056437.4 | |
CCZ1 | XM_047420465.1 | c.281A>G | p.Asn94Ser | missense_variant | 3/11 | XP_047276421.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCZ1 | ENST00000325974.9 | c.281A>G | p.Asn94Ser | missense_variant | 3/15 | 1 | NM_015622.6 | ENSP00000325681.6 | ||
CCZ1 | ENST00000628813.2 | c.218+154A>G | intron_variant | 2 | ENSP00000486988.1 | |||||
CCZ1 | ENST00000461592.1 | n.447A>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
CCZ1 | ENST00000478672.1 | n.300A>G | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000668 AC: 10AN: 149656Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
10
AN:
149656
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000338 AC: 6AN: 177648Hom.: 0 AF XY: 0.0000415 AC XY: 4AN XY: 96470
GnomAD3 exomes
AF:
AC:
6
AN:
177648
Hom.:
AF XY:
AC XY:
4
AN XY:
96470
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000107 AC: 155AN: 1452658Hom.: 1 Cov.: 31 AF XY: 0.0000983 AC XY: 71AN XY: 722448
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
155
AN:
1452658
Hom.:
Cov.:
31
AF XY:
AC XY:
71
AN XY:
722448
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000668 AC: 10AN: 149656Hom.: 0 Cov.: 26 AF XY: 0.0000822 AC XY: 6AN XY: 72976
GnomAD4 genome
AF:
AC:
10
AN:
149656
Hom.:
Cov.:
26
AF XY:
AC XY:
6
AN XY:
72976
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.281A>G (p.N94S) alteration is located in exon 3 (coding exon 3) of the CCZ1 gene. This alteration results from a A to G substitution at nucleotide position 281, causing the asparagine (N) at amino acid position 94 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MutPred
Gain of disorder (P = 0.1212);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at